Scarica l'app Stockscreener
69.99
1.14%
0.79
Dopo l'orario di chiusura:
69.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$69.20
Aprire:
$69.125
Volume 24 ore:
2.47M
Relative Volume:
0.89
Capitalizzazione di mercato:
$31.81B
Reddito:
$5.30B
Utile/perdita netta:
$199.54M
Rapporto P/E:
162.77
EPS:
0.43
Flusso di cassa netto:
$1.24B
1 W Prestazione:
+2.12%
1M Prestazione:
+2.81%
6M Prestazione:
+1.79%
1 anno Prestazione:
+9.14%
Intervallo 1D:
$68.80
$70.00
Intervallo di 1 settimana:
$67.96
$70.00
Portata 52W:
$56.68
$71.36
Ventas Inc Stock (VTR) Company Profile
Nome
Ventas Inc
Settore
Industria
Telefono
(312) 660-3800
Indirizzo
300 N LASALLE STREET, CHICAGO, IL
Confronta VTR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
69.99 | 31.45B | 5.30B | 199.54M | 1.24B | 0.43 |
|
WELL
Welltower Inc
|
178.14 | 117.85B | 9.27B | 1.14B | 1.60B | 1.77 |
|
DOC
Healthpeak Properties Inc
|
19.15 | 13.21B | 2.80B | 279.29M | 1.20B | 0.40 |
|
CTRE
Caretrust Reit Inc
|
34.68 | 7.64B | 219.54M | 99.24M | 205.68M | 0.72 |
|
AHR
American Healthcare Reit Inc
|
42.01 | 7.04B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-19 | Iniziato | UBS | Neutral |
| 2025-06-23 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Iniziato | Deutsche Bank | Buy |
| 2024-01-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-10-11 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-10-03 | Iniziato | Wedbush | Neutral |
| 2023-09-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Iniziato | Wells Fargo | Overweight |
| 2022-11-01 | Reiterato | Credit Suisse | Outperform |
| 2022-11-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-23 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | CapitalOne | Overweight |
| 2022-05-18 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-02-01 | Iniziato | Credit Suisse | Neutral |
| 2022-01-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-12-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-11-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Ripresa | Mizuho | Neutral |
| 2021-06-15 | Iniziato | Wolfe Research | Outperform |
| 2021-06-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Aggiornamento | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Iniziato | Robert W. Baird | Neutral |
| 2020-11-30 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2020-11-10 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-09-08 | Downgrade | Argus | Buy → Hold |
| 2020-09-02 | Ripresa | Stifel | Hold |
| 2020-08-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Downgrade | Jefferies | Buy → Underperform |
| 2020-02-28 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-12-20 | Ripresa | Mizuho | Neutral |
| 2019-12-10 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2019-10-30 | Downgrade | Stifel | Buy → Hold |
| 2019-10-28 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Ventas Inc Borsa (VTR) Ultime notizie
Will Ventas Inc. stock maintain strong growthWeekly Trade Recap & Risk Controlled Swing Alerts - newser.com
News | Ventas secures $475 million CMBS loan on Pennsylvania life sciences buildings - CoStar
Does Ventas' (VTR) Steady Dividend Reflect Strong Fundamentals or Limit Strategic Flexibility? - Yahoo Finance
Is Ventas Inc. forming a reversal patternJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Using economic indicators to assess Ventas Inc. potential2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Real time scanner hits for Ventas Inc. explainedMarket Risk Summary & Momentum Based Trading Ideas - newser.com
What does recent volatility data suggest for Ventas Inc.Weekly Market Report & Capital Efficiency Focused Ideas - newser.com
What analysts say about Ventas Inc stockInsider Selling Patterns & Outstanding Return Portfolio - earlytimes.in
Ventas (VTR): Assessing Valuation as Portfolio Shifts Target Senior Housing and Healthcare Growth - simplywall.st
TD Private Client Wealth LLC Boosts Stake in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Shares Acquired by State of Alaska Department of Revenue - MarketBeat
3 REITs With 15% Upside Paying Consistent Dividends Today - TIKR.com
Ex-Dividend Reminder: First Bancorp, Ventas and Safehold - Nasdaq
Old North State Wealth Management LLC Trims Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas Stock Rallies 16.3% Year to Date: Will the Trend Last? - Yahoo Finance
Ventas, GIC to Secure $475M for Office Portfolio - CommercialSearch
Public Employees Retirement System of Ohio Has $49.16 Million Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas (NYSE:VTR) Earns Neutral Rating from Analysts at UBS Group - MarketBeat
Ventas, Inc. $VTR Shares Sold by BDF Gestion - MarketBeat
Moody National Bank Trust Division Invests $964,000 in Ventas, Inc. $VTR - MarketBeat
Busey Bank Has $6.89 Million Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Oppidan sells Pillars of Prospect Park senior living facility near U of M for $140M - The Business Journals
Pillars of Prospect Park sells for $140M to Chicago REIT - Finance & Commerce
VTRVentas Reports 2025 First Quarter Results - ADVFN
4,573 Shares in Ventas, Inc. $VTR Purchased by Family Wealth Partners LLC - MarketBeat
Ventas, Inc. $VTR Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Ventas, Inc. Announces Quarterly Dividend of $0.48 (NYSE:VTR) - MarketBeat
What Ventas (VTR)'s Raised 2025 FFO Guidance and $600M Acquisition Mean for Shareholders - simplywall.st
Peter J. Bulgarelli Sells 406 Shares of Ventas (NYSE:VTR) Stock - MarketBeat
If 2026 Is 2008 Redux, You’ll Want to Own This 8.4% Dividend - Investing.com
Ventas Inc Azioni (VTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):